SHSE:603858 (China)
Â
Class A
Â¥
15.66
-0.14 (-0.89%)
Aug 5
Business Description
Shandong Buchang Pharmaceuticals Co Ltd
ISIN : CNE100002FV6
Share Class Description:
SHSE:603858: Class ATotal Employee Number:
7,237Compare
Compare
Traded in other countries / regions
603858.China Index Membership
SSE Composite IndexCSI 500 IndexCSI 300 Index IPO Date
2016-11-08Description
Shandong Buchang Pharmaceuticals Co Ltd is engaged in research and development, production and sales of Chinese patent medicines.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | 6.67 | |||||
Interest Coverage | 12.94 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.27 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6 | |||||
3-Year FCF Growth Rate | -21.2 | |||||
3-Year Book Growth Rate | -5.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.36 | |||||
9-Day RSI | 52.73 | |||||
14-Day RSI | 52.73 | |||||
3-1 Month Momentum % | -6.02 | |||||
6-1 Month Momentum % | -13.31 | |||||
12-1 Month Momentum % | -16.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 382.22 | |||||
Days Sales Outstanding | 16.96 | |||||
Days Payable | 207.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.47 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 2.7 | |||||
Forward Dividend Yield % | 3.61 | |||||
5-Year Yield-on-Cost % | 0.56 | |||||
3-Year Average Share Buyback Ratio | 1.6 | |||||
Shareholder Yield % | 2.15 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.31 | |||||
Operating Margin % | 13.16 | |||||
Net Margin % | 3.2 | |||||
EBITDA Margin % | 5.65 | |||||
FCF Margin % | 2.93 | |||||
OCF Margin % | 3.81 | |||||
ROE % | 3.59 | |||||
ROA % | 1.9 | |||||
ROIC % | 4.28 | |||||
3-Year ROIIC % | 115.78 | |||||
ROC (Joel Greenblatt) % | 13.19 | |||||
ROCE % | 5.25 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 43.87 | |||||
PE Ratio without NRI | 16.5 | |||||
Shiller PE Ratio | 17.4 | |||||
Price-to-Owner-Earnings | 301.15 | |||||
PS Ratio | 1.39 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 2.32 | |||||
Price-to-Free-Cash-Flow | 48.02 | |||||
Price-to-Operating-Cash-Flow | 37.13 | |||||
EV-to-EBIT | 28.23 | |||||
EV-to-EBITDA | 28.23 | |||||
EV-to-Revenue | 1.59 | |||||
EV-to-FCF | 54.44 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 0.99 | |||||
Price-to-Graham-Number | 1.31 | |||||
Earnings Yield (Greenblatt) % | 3.54 | |||||
FCF Yield % | 2.07 | |||||
Forward Rate of Return (Yacktman) % | 5.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Buchang Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 11,669.08 | ||
| EPS (TTM) (Â¥) | 0.357 | ||
| Beta | 1.0097 | ||
| 3-Year Sharpe Ratio | -0.53 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 20.43 | ||
| 14-Day RSI | 52.73 | ||
| 14-Day ATR (Â¥) | 0.473064 | ||
| 20-Day SMA (Â¥) | 15.7665 | ||
| 12-1 Month Momentum % | -16.62 | ||
| 52-Week Range (Â¥) | 14.01 - 20.58 | ||
| Shares Outstanding (Mil) | 1,054.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Buchang Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Buchang Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.180000 Cash Dividend | 2026-08-06 | In 1 day | ||
| CNY 0.390000 Cash Dividend | 2025-09-26 | 18.62 (+0.32%) | ||
| CNY 0.126000 Cash Dividend | 2024-08-20 | 15.46 (-0.19%) | ||
| 1.3:1 Stock Split | 2019-08-19 | 20.82 (-0.81%) | ||
| 1.3:1 Stock Split | 2018-08-17 | 23.37 (+1.28%) |
Show
Entries
Shandong Buchang Pharmaceuticals Co Ltd Frequently Asked Questions
What is Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858)'s stock price today?
The current price of SHSE:603858 is ¥15.66. The 52 week high of SHSE:603858 is ¥20.58 and 52 week low is ¥14.01.
When is next earnings date of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858)?
The next earnings date of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) is .
Does Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) is 2.47% (As of Today), Highest Dividend Payout Ratio of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) was 3.64. The lowest was 0.41. And the median was 0.76. The  Forward Dividend Yield % of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) is 3.61%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shandong Buchang Pharmaceuticals Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers